Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life of several hundred thousand worldwide. However, so far no approved vaccine or drug therapy is available for treatment of virus infection. Convalescent plasma has been considered a potential modality for COVID-19 infection. One hundred eighty-nine COVID-19 positive patients including 115 patients in plasma therapy group and 74 patients in control group, registered in the hospitals with confirmed COVID-19 infection, entered this multi-center clinical study. Comparison of outcomes including all-cause mortality, total hospitalization days and patients� need for intubation between the two patient groups shows that total of 98 (98.2 ) of patients who received convalescent plasma were discharged from hospital which is substantially higher compared to 56 (78.7 ) patients in control group. Length of hospitalization days was significantly lower (9.54 days) in convalescent plasma group compared with that of control group (12.88 days). Only 8 patients (7) in convalescent plasma group required intubation while that was 20 in control group. This clinical study provides strong evidence to support the efficacy of convalescent plasma therapy in COVID-19 patients and recommends this treatment for management of these patients. Clinical efficacy, immediate availability and potential cost effectiveness could be considered as main advantages of convalescent plasma therapy. © 2020 Elsevier Lt

A current-matrix model for metallic and dielectric postwall waveguides

Waveguide structure integration in planar substrates for use in microwave components has received considerable attention in recent years. Waveguides with side walls consisting of cylindrical posts (postwall waveguides or PWWGs) are of interest, since they are compatible with standard PCB fabrication technology and exhibit low loss. In this paper we present an electromagnetic model for PWWG building blocks, whose characteristics are described entirely in terms of equivalent electric and magnetic surface currents at predefined port interfaces consistent with Lorentz's reciprocity theorem. Introducing input and output surface currents, we determine the response of a block for a given port excitation. The expansion of the currents in terms of suitable bases results in a matrix that relates input and output currents. The scattering parameters of a building block are determined by expressing waveguide modes in terms of these bases. This facilitates the future integration of PWWG components in a microwave circuit simulator. We validate our model by comparing the results for simulated and measured uniform PWWGs implemented with metallic and dielectric posts

Temperature‐Responsive Photonic Devices Based on Cholesteric Liquid Crystals

Cholesteric liquid crystals (CLCs) are a major class of photonic materials that display selective reflection properties arising from their helical ordering. The temperature response of CLCs, comprising of dynamic reflection color changes upon variation of temperature, can be exploited using material systems consisting of small mesogenic molecules, polymer‐dispersed liquid crystals (PDLCs), polymer‐stabilized liquid crystals (PSLCs), or liquid‐crystalline polymers. Taking advantage of the easy processability and flexibility of the molecular design, these temperature‐responsive CLCs have been fabricated into different forms of photonic devices, including cells, coatings, free‐standing films, and three‐dimensional objects. Temperature‐responsive devices developed from CLCs could be integrated for application in temperature sensors, energy‐saving smart windows, smart labels, actuators, and adding aesthetically pleasing features to common objects. This review summarizes the device capabilities of the different material systems of temperature‐responsive CLCs: small mesogenic molecules, PDLCs, PSLCs, and CLC polymers. For each system, examples of different device forms are presented, with their temperature responsiveness and the underlying mechanisms discussed. Additionally, the potential of each material system for future device applications and product developments is envisioned

Eletroconvulsoterapia na depressão maior: aspectos atuais Electroconvulsive therapy in major depression: current aspects

OBJETIVO: A eficácia da eletroconvulsoterapia em tratar sintomas depressivos está estabelecida por meio de inúmeros estudos desenvolvidos durante as últimas décadas. A eletroconvulsoterapia é o tratamento biológico mais efetivo para depressão atualmente disponível. O objetivo deste estudo foi demonstrar o papel da eletroconvulsoterapia no tratamento da depressão e destacar aspectos atuais relativos à sua prática. MÉTODO: Foram revisados na literatura estudos de eficácia, remissão de sintomas, fatores preditores de resposta, assim como aspectos atuais acerca da qualidade de vida, percepção dos pacientes, mecanismo de ação, técnica e prejuízo cognitivos. RESULTADOS: Os principais achados desta revisão foram: 1) a eletroconvulsoterapia é mais efetiva do que qualquer medicação antidepressiva; 2) a remissão da depressão com a eletroconvulsoterapia varia, em geral, de 50 a 80%; 3) Ainda é controverso o efeito da eletroconvulsoterapia nos níveis de fator neurotrófico derivado do cérebro (acho que aqui pode colocar entre parenteses o "BNDF"); 4) a eletroconvulsoterapia tem efeito positivo na melhora da qualidade de vida; 5) os pacientes submetidos à eletroconvulsoterapia, em geral, têm uma percepção positiva do tratamento. CONCLUSÃO: A eletroconvulsoterapia permanece sendo um tratamento altamente eficaz em pacientes com depressão resistente. Com o avanço da sua técnica, a eletroconvulsoterapia tornou-se um procedimento ainda mais seguro e útil tanto para a fase aguda, quanto para a prevenção de novos episódios depressivos.<br>OBJECTIVE: The efficacy of electroconvulsive therapy in treating depressive symptoms has been established by means of innumerable studies developed along the last decades. Electroconvulsive therapy is the most effective biological treatment for depression currently available. The objective of this study was to demonstrate the role of electroconvulsive therapy in the treatment of depression and highlight present aspects related to its practice. METHOD: We reviewed in the literature studies on efficacy, symptom remission, predictive response factors as well as current aspects regarding quality of life, the patients' perception, mechanism of action, technique and cognitive impairment. RESULTS: The main results found in the this revision were: 1) electroconvulsive therapy is more effective than any antidepressant medication; 2) the remission of depression with electroconvulsive therapy varies, in general, from 50 to 80%; 3) The effect of electroconvulsive therapy in brain-derived neurotrophic factor levels is still controversial; 4) electroconvulsive therapy has a positive effect in the improvement of quality of life; 5) patients submitted to electroconvulsive therapy have, in general, a positive perception about the treatment. CONCLUSION: Electroconvulsive therapy remains a highly efficacious treatment in treatment-resistant depression. With the improvement of its technique, electroconvulsive therapy has become an even safer and more useful procedure both for the acute phase and for the prevention of new depressive episodes